About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Kinesia HomeView - Home Diary Comparison | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT01920425

Kinesia HomeView - Home Diary Comparison

The objective is to compare the sensitivity and test-retest reliability of Kinesia HomeView to electronic and hand-written diaries for tracking medication state in the home. Demonstrating comparable o...

Lead sponsor: Great Lakes NeuroTechnologies Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Great Lakes NeuroTechnologies Inc.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Clinical diagnosis of Parkinson's disease
•On a stable antiparkinsonian medication regimen that includes levodopa for at least 4 weeks
•Experiencing dyskinesia more than 25% of the waking day (score ≥ 2 on Unified Parkinson's Disease Rating Scale item 32)
•With dyskinesias at least moderately disabling (score ≥ 2 on Unified Parkinson's Disease Rating Scale item 33)
•Capable of accurately completing diaries
•Capable of accurately using Kinesia HomeView

Exclusion Criteria

•Significant medical or psychiatric illness
•Subjects not capable of following the required clinical instructions
•Serious medical conditions that would compromise safety

Related studies

At-home taVNS for Neurorehabilitation in Parkinson's Disease

NCT07536022 · Parkinson's Disease

Prospective Multicenter Registry Study of Multiple System Atrophy in China

NCT07644013 · Multiple System Atrophy, Parkinson's Disease, and more

Sensing in Sleep Deep Brain Stimulation

NCT07636720 · Parkinson's Disease and Parkinsonism, Dyssomnia

Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)

NCT06916507 · Parkinson's Disease

Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease

NCT07398157 · PD - Parkinson's Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 12, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment2

Start dateJul 2013

Last updatedJan 12, 2016

Condition

Parkinson's Disease

Locations shown

Great Lakes NeuroTechnologies Inc

Valley View, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 12, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions